PERIMENOPAUSE. MENOPAUSE. A LITTLE SPACE FOR YOU.

Reviews 5 MIN READ

Hone Health HRT review: membership, testing and the medicine bill

What Hone’s women’s hormone program includes, and what its advertised membership price leaves separate.

Hone Health offers a women’s menopause program built around testing, a clinician consultation and ongoing membership. Its menu includes estrogen and progesterone products alongside other treatments, so the first question is which part of that larger service addresses your actual symptoms.

We checked Hone’s public menopause page and September 2026 help-center information on September 26, 2026. This review examines the offer and its limits. It does not establish personal eligibility, predict results or treat a larger laboratory panel as proof of better care.

The price has several parts

Hone’s women’s Premium information lists a $65 initial laboratory step, then a $155 monthly membership, with medication charged separately. Follow-up testing and consultations are described as included in that membership. Its lower-priced Basic plan should not be used as the price of a menopause hormone-treatment program.

The headline medicine prices on the menopause page also say “plus membership.” Request the cost of the entire proposed regimen, including any second medicine, before comparing it with another provider. If a clinic offers estrogen and progesterone separately, one product’s starting price will not tell you what the combined monthly payment would be.

Check which testing pathway you are buying

Hone describes both in-laboratory and at-home options. Its landing page mentions a home visit where available, while the membership FAQ says testing method can affect the starting price. Confirm the collection method, local availability and final charge for your address rather than assuming every home option costs the same.

The women’s Premium page does not require the confirmatory test described for certain men’s treatment pathways. This is a useful distinction when reading a help center that covers multiple programs. Ask which instructions apply to the women’s plan and whether recent outside results can be considered before paying for another collection.

A testing schedule is a service policy

A clinic can require testing within its program without that becoming a universal rule for menopause diagnosis. NICE guidance, for example, describes identifying typical menopause in otherwise healthy people aged 45 or older from history and symptoms without routine laboratory testing. Other medical concerns can still make targeted tests appropriate.

Our menopause blood-test guide explains the difference between diagnosing the transition and investigating another possible problem. Ask what each proposed result would change in your care. A useful answer connects the test to a decision, rather than promising that a single panel will explain every symptom.

The actual prescription needs its own review

Hone’s menopause catalog includes patches, gel, oral progesterone, local vaginal products and compounded preparations such as biest cream. Ask for the complete name, formulation and approval status of the medicine you are offered. Access to a broad catalog does not mean every product is equally supported for every purpose.

Compounded drugs are not FDA approved. If a compounded progesterone skin cream is proposed alongside systemic estrogen, discuss the evidence for uterine protection with the prescriber. Our progesterone guide explains why a familiar ingredient does not make all routes interchangeable. The clinical reason for a compound should be specific to your circumstances.

Testosterone claims require a narrower question

Hone also advertises testosterone products. That does not establish a general treatment for fatigue, memory complaints, bone health or every change in sexual interest. Current specialist guidance focuses on carefully assessed, distressing low sexual desire; broad promises about energy or healthy aging go beyond that evidence.

The FDA’s August 2026 workshop notice states that there are no FDA-approved testosterone indications for menopausal women. Read our testosterone and menopause guide before interpreting a product listing as approval for your intended use. Ask about off-label prescribing, formulation, monitoring and the point at which an ineffective treatment would be reconsidered.

Know which care model applies

Women’s Premium starts with a live video consultation. Hone separately describes an intake-based service without membership or a live encounter, but its published medication list for that service does not establish the same menopause-HRT pathway. Do not assume the no-appointment description applies to a hormone plan you saw elsewhere on the site.

Membership continues to bill even during a month without medication, according to the FAQ. Cancellation through support takes effect at the end of the current billing period. Ask how to arrange medical follow-up and obtain records if you end membership; canceling a payment relationship is not the same as completing a clinical handoff.

Where to compare next

Hone may be worth investigating if you want a program combining scheduled clinical contact and a defined testing process. The question is whether that structure fits your needs and budget, not whether more tests necessarily make it better. We have not verified superior clinical outcomes over another service.

See Hone versus Joi for a comparison of two programs that separate medication from care fees. The at-home testing shortlist helps compare collection arrangements while keeping the decision about whether testing is needed with a clinician.

For route-specific comparisons, see the estrogen-gel shortlist and oral-progesterone shortlist, which include the care fee as a separate budget question.

THE READING BEHIND THE ARTICLE

Sources & reading notes

Provider pages describe their own services and commercial terms. They are not independent evidence of better clinical results. Prices and access can change.

  1. Hone Health: women’s menopause treatments and prices ↗
  2. Hone Health: Premium membership for women ↗
  3. Hone Health: membership, testing and cancellation questions ↗
  4. Hone Health: separate asynchronous care pathway and medication list ↗
  5. NICE: menopause diagnosis and management recommendations ↗
  6. FDA: understanding the risks of compounded drugs ↗
  7. British Menopause Society: progestogens and endometrial protection (May 2026) ↗
  8. British Menopause Society: testosterone replacement in menopause (May 2026) ↗
  9. FDA: testosterone therapy in menopausal women workshop notice (August 2026) ↗

Checked September 26, 2026. Our editorial process · Promotion disclosure. This article is educational and cannot determine which treatment is right for you.

A FREE GIFT FOR YOUR NEXT STEP

Keep the questions.
Take the kit with you.

Get the Before-You-Book Kit: 12 questions to bring, a true-cost worksheet and a side-by-side provider sheet. Plus five short daily emails to help you use it.

Take a look inside ↗